Kettering Health Dayton, formerly known as Grandview Medical Center, is a 317-bed teaching hospital located on the north side of Dayton, Ohio, United States, in the Five Oaks part of the larger area of Dayton View. Founded in 1926, Kettering Health Dayton is a part of the Kettering Health network.

There are 317 beds in Grandview Hospital.

During the past decade, Grandview Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 152 clinical trials were completed, i.e. on average, 2533.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 34 clinical trials were completed. i.e. 3400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Grandview Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 70 trials, followed by "Alliance for Clinical Trials in Oncology" with 69 trials sponsored, "SWOG Cancer Research Network" with 57 trials sponsored, "Radiation Therapy Oncology Group" with 11 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grandview Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 170 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "NCIC Clinical Trials Group" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator and "SWOG Cancer Research Network" with 11 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Grandview Hospital" are "Breast Cancer" (35 trials), "Lung Cancer" (21 trials), "Lymphoma" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (13 trials) and "Colorectal Cancer" (10 trials). Many other conditions were trialed in "Grandview Hospital" in a lesser frequency.

Most popular intervention types in "Grandview Hospital" are "Drug" (207 trials), "Other" (107 trials), "Biological" (91 trials), "Radiation" (43 trials) and "Procedure" (35 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (45 trials), "placebo" (28 trials), "Paclitaxel" (25 trials), "Quality-of-Life Assessment" (24 trials) and "Bevacizumab" (22 trials). Other intervention names were less common.

The vast majority of trials in "Grandview Hospital" are 182 trials for "All" genders, 54 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Grandview Hospital". undefined are not yet recruiting, 1 are recruiting, 54 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 157 completed trials in Grandview Hospital, undefined suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Grandview Hospital, 5 "Phase 1" clinical trials were conducted, 120 "Phase 2" clinical trials and 109 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".